K2414125计算溶液所需的质量、体积或浓度。
为什么选择此级别
提供 ≥99% 纯度，适用于对基线干扰要求严格的色谱和分析工作流程。
储存与运输
2-8°C储存,避光,干燥。低温运输 。请查阅批次 COA 获取详细规格。
质量文档
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
文献证明
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
概述
In Vitro
Capmatinib (INCB28060) inhibits c-MET phosphorylation with an IC 50 value of approximately 1 nM and a concentration of approximately 4 nM inhibits c-MET more than 90%, which is reversible and the effect is significantly reduced in several hours after the compound is removed and completely disappeared by 48 hours. Capmatinib (INCB28060) (0-10000 nM; 72 h) inhibits the proliferation of SNU-5, S114, H441 and U-87MG. Capmatinib (INCB28060) (0.06-62.25 nM; 2h) effectively inhibits phosphorylation of c-MET as well as c-MET pathway downstream effectors such as ERK1/2, AKT, FAK, GAB1, and STAT3/5. Capmatinib (INCB28060) (0.24-63 nM; over night) prevents HGF-stimulated H441 cell migration. Capmatinib (INCB28060) (0.5-50 nM; 20 min) suppresses phosphorylation of both EGFR and HER-3 rapidly. Capmatinib (INCB28060) (0-333 nM; 24 h) induces apoptosis in SNU-5 cells. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability AssayCell Line: SNU-5, S114, H441 and U-87MG Concentration: 0-10000 nM Incubation Time: 72 h Result: Inhibited the cell viability of SNU-5 and S114, as well as the colony formation of H441 and U-87MG, with IC 50 values of 1.2 nM, 12.4 nM, ~0.5 nM and 2 nM, respectively. Cell Migration AssayCell Line: H441 (stimulated with 50 ng/mL recombinant human HGF for 24h) Concentration: 0.24, 1, 4, 16 and 63 nM Incubation Time: Over night Result: Prevented HGF-stimulated H441 cell migration, with IC 50 of approximately 2 nM, and less cell migration at 16 nM. Western Blot AnalysisCell Line: SNU-5 Concentration: 0.06, 0.24, 0.98, 3.91, 15.63 and 62.25 nM Incubation Time: 2 h Result: Effectively inhibited phosphorylation of c-MET as well as c-MET pathway downstream effectors such as ERK1/2, AKT, FAK, GAB1, and STAT3/5. Western Blot AnalysisCell Line: H1993 cells Concentration: 0.5, 5 and 50 nM Incubation Time: 20 min Result: Suppressed phosphorylation of both EGFR and HER-3 rapidly and as effectively as the compound inhibited c-MET phosphorylation in H1993 cells. Apoptosis AnalysisCell Line: SNU-5 cells Concentration: 0.017, 0.15, 1.37, 12.33, 111 and 333 nM Incubation Time: 24 h Result: Effectively induced DNA fragmentation.
In Vivo
Capmatinib (INCB28060) (1-30 mg/kg; PO, twice daily, for 2 weeks) exhibits dose-dependent inhibition of tumor growth, and shows well tolerance at all doses during the treatment periods, with no evidence of overt toxicity or weight loss in U-87MG tumor mice model . Capmatinib (INCB28060) (0.03-10 mg/kg; PO, single dosage) causes inhibition of c-MET phosphorylation in S114 tumor mice model . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Female Balb/c nu/nu mice (inoculated subcutaneously with 5×10 6 U-87MG glioblastoma cells) Dosage: 1, 3, 10 and 30 mg/kg Administration: PO, twice daily, for 2 weeks Result: Exhibited dose-dependent inhibition of tumor growth with 35% and 76% at 1 and 3 mg/kg once daily; resulted in partial regressions in 6 of 10 U-87MG tumor-bearing mice at 10 mg/kg once daily; and showed well tolerance at all doses during the treatment periods, with no evidence of overt toxicity or weight loss. Animal Model: Female Balb/c nu/nu mice (inoculated subcutaneously with 4×10 6 S114 tumor cells) Dosage: 0.03, 0.1, 0.3, 1, 3 and 10 mg/kg Administration: PO, single dosage Result: Caused approximately 50% and 90% inhibition of c-MET phosphorylation at 0.03 and 0.3 mg/kg after administration of 30 min, and inhibition of phospho-c-MET exceeded 90% after 7 hours.
Form:Solid
规格
英文别名
NVP-INC280 2HCl.H2O | NVP-INC280 2HCl.H2O | INC-280 2HCl.H2O | INCB28060 2HCl.H2O | INC280 dihydrochloride hydrate | INCB-28060 dihydrochloride hydrate
规格或纯度
≥99%
英文名称
Capmatinib dihydrochloride hydrate
生化机理
Capmatinib (INC280; INCB28060) dihydrochloride hydrate 是一种有效的、口服活性的、选择性的、ATP 竞争性的 c-Met 激酶抑制剂 (IC50=0.13 nM)。Capmatinib dihydrochloride hydrate 可抑制 c-MET 的磷酸化，以及 c-MET 通路下游效应蛋白如 ERK1/2、AKT、FAK、GAB1 和 STAT3/5。Capmatinib dihydrochloride hydrate 有效抑制 c-Met 依赖性肿瘤细胞的增殖和迁移，并有效诱导细胞凋亡。在肿瘤小鼠模型中表现出抗肿瘤活性。Capmatinib dihydrochloride hydrate 主要由 CYP3A4 和醛氧化酶代谢。
储存条件
2-8°C储存,避光,干燥
运输条件
低温运输
作用类型
抑制剂
作用机制
肝细胞生长因子受体抑制剂
纯度
≥99%
名称和识别符
PubChem SID
分子类型
小分子
IUPAC Name
2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide;hydrate;dihydrochloride
INCHI
1S/C23H17FN6O.2ClH.H2O/c1-25-22(31)18-6-5-16(11-19(18)24)21-13-28-23-27-12-17(30(23)29-21)10-14-4-7-20-15(9-14)3-2-8-26-20;;;/h2-9,11-13H,10H2,1H3,(H,25,31);2*1H;1H2
InChi Key
COWBUPJEEDYWKD-UHFFFAOYSA-N
Smiles
CNC(=O)C1=C(C=C(C=C1)C2=NN3C(=CN=C3N=C2)CC4=CC5=C(C=C4)N=CC=C5)F.O.Cl.Cl
Isomeric SMILES
CNC(=O)C1=C(C=C(C=C1)C2=NN3C(=CN=C3N=C2)CC4=CC5=C(C=C4)N=CC=C5)F.O.Cl.Cl
PubChem CID
分子量
503.36
技术文档
高级数据
系统学分类
分类树（Taxonomy Tree）
| 界（kingdom) | 有机化合物 |
|---|---|
| 超类（Superclass) | 有机杂环化合物 |
| 类（Class) | 喹啉及其衍生物 |
| 亚类（Subclass） | 暂无 |
| 中间层级节点（Intermediate Tree Nodes） | 暂无 |
| 直接上位类(Direct Parent) | 喹啉及其衍生物 |
| 其他上位类（Alternative Parents） | 2-卤苯甲酸及其衍生物 咪唑并[1,2-a][1,2,4]三嗪 苯甲酰胺类 苯甲酰衍生物 氟苯类 吡啶及其衍生物 N-取代咪唑 芳基氟化物 1,2,4-三嗪 乙烯基卤化物 杂芳族化合物 仲羧酸酰胺 氮杂环化合物 有机光子化合物 有机氧化合物 有机氮化合物 有机氟化物 有机氧化物 盐酸盐 碳氢化合物衍生物 |
| 分子骨架（Molecular Framework) | 芳香族杂多环化合物 |
| 取代基（Substituents） | 1,2,4-三嗪 - 2-呋喃酮 - 芳香族杂多环化合物 - 芳基氟化物 - 芳基卤化物 - 氮杂环 - 吡唑 - 苯甲酰胺 - 苯基化合物 - 苯甲酸或衍生物 - 苯甲酰 - 羧酰胺基 - 羧酸衍生物 - 氟萘 - 卤苯 - 卤代苯甲酸或其衍生物 - 杂芳香族化合物 - 烃衍生物 - 氟氯烃 - Imidazo[1,2-a][1,2,4]triazine - 咪唑 - 单环苯基基团 - N-取代咪唑 - 有机硝基化合物 - 有机氧化物 - 有机氧化合物 - 有机氟化物 - 有机卤化物 - 有机氮化合物 - 有机氧化合物 - 有机氮化合物 - 吡啶 - 喹啉胺 - 醛基 - 三嗪 - 乙烯醯基鹵化物 |
| 描述（Description） | 该化合物属于喹啉及其衍生物类有机化合物。这类化合物含有喹啉骨架，其结构为苯环与嘧啶环并联形成苯并[b]氮杂苯环。 |
| 外部描述符（External Descriptors） | 暂无 |
三维结构
交互式化学结构模型
化学和物理性质
溶解性
DMSO : 20.83 mg/mL (41.38 mM; ultrasonic and warming and heat to 60°C)
敏感性
对光及湿度敏感
分子量
503.400 g/mol
XLogP3
氢键供体数Hydrogen Bond Donor Count
4
氢键受体数Hydrogen Bond Acceptor Count
7
可旋转键计数Rotatable Bond Count
4
精确质量Exact Mass
502.109 Da
单同位素质量Monoisotopic Mass
502.109 Da
拓扑极表面积Topological Polar Surface Area
86.100 Ų
重原子数Heavy Atom Count
34
形式电荷Formal Charge
0
复杂度Complexity
637.000
同位素原子数Isotope Atom Count
0
定义的原子立体中心计数Defined Atom Stereocenter Count
0
未定义的原子立体中心计数Undefined Atom Stereocenter Count
0
定义的键立体中心计数Defined Bond Stereocenter Count
0
未定义的键立体中心计数Undefined Bond Stereocenter Count
0
所有立体化学键的总数The total count of all stereochemical bonds
0
共价键合单元计数Covalently-Bonded Unit Count
4
质检证书（CoA,COO,BSE/TSE 和分析图谱)
C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:
溶液计算器
产品仅提供给经过验证的企业、机构和合格的专业人员用于研发。不适用于人类、动物、诊断或治疗。
Copyright © 2023至今 上海阿拉丁生化科技股份有限公司 保留所有权利。
危险品化学品经营许可证（带存储）